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Experimental observations indicate that tissue macrophages deployed in great numbers
at critical anatomic sites such as the liver, spleen, and lung are major targets for glucocor-
ticoids compromising natural resistanceof the host. Therapeutic concentrations ofglucocor-
ticoids appear to prevent destruction of microorganisms ingested by macrophages with-
out interfering with phagocytosis, phagolysosomal fusion, and/or secretion of reactive
oxygen intermediates. These findings indicate that at the cellular level the glucocorticoid
target should be sought for in the nonoxidative armature of the phagocyte and that nonox-
idative killing systems of resident tissue macrophages play an important role in natural
resistance to opportunistic pathogens. Glucocorticoids do not prevent lymphokine-induced
activation of oxidative killing systems. Thus, lymphokines such as interferon-y can re-
store the microbicidal activity of macrophages functionally impaired by glucocorticoids.
Counterbalance of the suppressive effect of glucocorticoids by lymphokines might only
be possible, however, for pathogens susceptible to oxidative killing and not for microor-
ganisms that are more resistant to reactive oxygen intermediates such as Aspergillusspores
and Nocardia, opportunists that appear to beparticularly associated with hypercortisolism.
From studies of populations of patients receiving
glucocorticoid therapy [1-3] or suffering from endo-
genous hypercortisolism [4], it has become clear that
glucocorticoids affect host resistance to a broad
range of microorganisms. Analysis of large popula-
tions undergoing therapy with glucocorticoids sug-
gests that a daily dose equal to or greater than the
equivalent of 50-100 mg of prednisone increases the
patient's risk of developing an opportunistic infec-
tion [2, 3]. Accordingly, a recent survey of infectious
complications of endogenous hypercortisolism in-
dicates that opportunistic infections develop when
plasma cortisol levels are 0.4-1.8 ug/rnl [4]. These
concentrations of endogenous hormone correspond
fairly well to the aforementioned dose of predni-
sone [5, 6].
Glucocorticoids have a bewildering array of ef-
fects on host defense systems, including effects on
phagocytes and on cell-mediated and humoral im-
munity (reviewed in [7]), but the relevance of in-
dividual immunosuppressive mechanisms to the in-
creased vulnerability of hypercortisolemic patients
to infection has not been defined. Furthermore, it
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is not clear why infections with some pathogens, such
as Aspergillus, Nocardia, and Pneumocystis, are par-
ticularly associated with hypercortisolism [2, 4].
Our interest in the mechanisms by which glucocor-
ticoids damage host resistance arose from our studies
on natural resistance to Aspergillus, which indicated
that glucocorticoids rendered "resting" macrophages
unable to confine and kill ingested spores [8]. Be-
cause glucocorticoid-mediated impairment of the
antimicrobial function of tissue macrophages is crit-
ical for the immunosuppressive effect in aspergillo-
sis, we studied the importance of such mechanisms
for other infections. This paper outlines our recent
experimental findings on how glucocorticoids im-
pair antimicrobial activity of macrophages and how
this impairment depends on the state of macrophage
activation.
Impairment of Conidiacidal Activity of
Macrophages by Glucocorticoids
Host resistance to conidia, the spores of Aspergillus,
is largely independent of T lymphocytes, neutrophil
granulocytes, and blood monocytes but is highly sus-
ceptible to damage by glucocorticoids (figure 1).Hu-
moral immunity appears not to be of importance [8].
By exclusion, the candidate for the glucocorticoid-
sensitive target is the resident macrophage, a sugges-
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tion made more than 20 years ago by Sidransky [9].
Impairment of the conidiacidal activity of mononu-
clear phagocytes by glucocorticoids results from a
direct effect on the phagocyte (i.e., impairment is not
mediated through systems modulating macrophage
function), as readily demonstrated by exposing pure
preparations of human mononuclear phagocytes to
glucocorticoids [8, 10].This treatment results in a loss
of anticonidial activity comparable to that seen in
murine macrophages previouslyexposed to glucocor-
ticoid in vivo or in vitro [8]. It is of note that impair- .
ment of the anticonidial activity occurs at pharmaco-
logic concentrations (i,e., 10-8 M dexamethasone).
This observation, together with the observations in
mice, indicates that impaired killing (mainly by al-
veolar macrophages) of Aspergillus conidia is also
operative in glucocorticoid-treated patients and thus
contributes to the susceptibility of hypercortisolemic
patients to aspergillosis (effects of cortisone on nat-
ural immunity against hyphae provided by neutro-
phil granulocytes are discussed in [8]).
Impairment of Antibacterial Activity of
Macrophages by Glucocorticoids
Glucocorticoids are known to damage host resistance
to intracellular bacteria [11, 12]. North [11] demon-
strated that cortisone dramatically lowered resistance
of mice to Listeria monocytogenes and provoked
rapid proliferation of bacteria in the livers of gluco-
corticoid-treated animals. Because infiltration by
small lymphoid mononuclear cells in the livers of
glucocorticoid-treated animals was markedly re-
duced in comparison to that in control animals, and
because the first studies showing an impaired anti-
microbial activity of glucocorticoid-treated mono-
nuclear phagocytes were not yet available [13, 14],
North speculated that a suppression of the influx
and/or the proliferation of lymphocytes was respon-
sible for the immunosuppressive effect of glucocor-
ticoids in murine listeriosis and hence that in this
model lymphocytes were the cortisone target.
Our observation that glucocorticoids affect mac-
rophages in the aspergillosis model and the fact that
the glucocorticoid effect in North's experiments oc-
curred before T cell-mediated control of listeriosis
was apparent in control animals made us curious
about whether mononuclear phagocytes rather than
T cells were the target for the immunosuppressive
effect of glucocorticoids in the murine listeriosis
model. Indeed, when wecompared the effects ofcor-
tisone in normal and athymic mice, we found that
cortisone had virtually the same effect on the course
of listeriosis in animals with functional T lympho-
cytes as in those without (figure 2). These experi-
ments thus show that T lymphocytes cannot be the
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Figure 2. Comparison of the effect of cortisone acetate
(CA) on listeriosis in athymic (nude) BALB/c mice and
in their normallittermates. Cortisone was given at a daily
dosage of 1 mg per animal, starting 2 days before chal-
lenge and continuing until death, which invariably oc-
curred within 6 days in animals receiving the drug. The
challenge dose was 700 cfu of a wild-type strain of Listeria
monocytogenesin thymus-bearing mice (+/+), and 2,800
cfu in nude mice (nu/nu), to obtain an initial bacterial
count in the liver comparable to that in control mice. Each
point represents the mean of log cfu for four to sixanimals.
Figure is modified from [15].
critical target for the immunosuppressive effect of
glucocorticoids in this model of listeriosis and sug-
gest that, as in aspergillosis, resistance provided by
macrophages is affected by the steroid.
Ifhost resistanceprovided by mononuclear phago-
cytes is the main target for the immunosuppressive
effect of glucocorticoids in murine listeriosis, the
question arises whether the ability of mononuclear
phagocytes to accumulate at infectious sites is im-
paired [16] or, as in the aspergillosis model, the ac-
tivity of resident macrophages is damaged. Eventu-
ally, of course, both mechanisms could contribute
to the immunosuppressive effect of glucocorticoids.
It is of note that in the listeriosis model >90% of
the organisms injected iv are cleared rapidly by the
reticulohistiocytic system; >90070 of the challenge
dose is recoverable from the liver and spleen within
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10min of injection [17] (figures 3 and 4). This find-
ing is strong evidence for the localization of early
listerial infection in resident tissue macrophages. Cir-
cumstantial evidence indicates that accumulation of
blood-derived mononuclear phagoeytes in listeric
livers is critical for the control of listeriosis in this
organ [18, 19]. Nevertheless, our observations indi-
cate that glucocorticoids interfere primarily with the
natural resistance provided by the resident macro-
phages that first encounter the bacteria. When we
attempted to duplicate the effect of glucocorticoids
on phagocyte recruitment by ablation of the bone
marrow with cytotoxic drugs, which rendered the
mice severelyleukopenic and unable to mount a cel-
lular inflammatory response, the course of listerio-
sis was unaffected (figures 3 and 5). This finding in-
dicates that accumulation of bone marrow-derived
phagocytes is not important for control of listerio-
sis during the first 48 h after infection, the exact time
period during which most of the immunosuppres-
sive effect of glucocorticoids is operative (figure 2).
Because antibody and other humoral factors do
not play important roles in murine listeriosis[l7],
these findings again point to the antimicrobial ac-
tivity of tissue macrophages as the critical target for
the immunosuppressive effect of glucocorticoids in
the listeriosis model of North. Again, when pure
preparations of mononuclear phagocytesare exposed
to pharmacologic concentrations of glucocorticoids
in vitro, the phagocytes lose their listericidal activ-
ity (figure 6) without undergoing any apparent non-
specific damage, as evidenced by parallel studies of
viability, phagocytic rate, and secretion of lysozyme
[10]. In agreement with these in vitro observations
on human blood-derived phagocytes are the find-
ings that glucocorticoids administered in vivo im-
pair the capacity of phagocytes to reduce the inocu-
lum and that tissue macrophages such as Kupffer
cells fail to control early bacterial growth (figures
3 and 4). Furthermore, experiments with Salmonella
typhimurium and Nocardia asteroides suggest that
glucocorticoid-induced damage to the antimicrobial
activity of macrophages is not limited to their activ-
ity against Aspergillus and Listeria [10].
Effect of Glucocorticoids on the Antimicrobial
Activity of Activated Macrophages
and on Macrophage Activation
The studies of North on the effects of glucocorti-
coids on murine listeriosis showed that mice become
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Figure 3. Comparison of the course
of early listeriosis in ICR mice im-
munosuppressed with nitrogen mus-
tard (HN2) or cortisone acetate and in
control mice. In spite of the high dose
of 1.8 x lOs Listeria monocytogenes
(strain EGD) organisms per animal, the
initial reduction of the challenge dose
and the early growth rate was impaired
only by cortisone but not by nitrogen
mustard (three doses of 50 ug), Fifteen
minutes after iv injection of the bacte-
ria, 88070-91070 of the challenge dose
was recoveredfrom the liver.Bone mar-
row suppression by nitrogen mustard
was monitored by blood counts (0gran-
ulocytes/mm" of blood). Each point
represents the mean value for five
animals (percentage of initial count in
panel A; loglO cfu/ml in panel B). Bars
give SD. The methods used were those
described in [15], except that the total
volume of the liver homogenate in the
experiment described above was 5 ml.
Figure 4. Effect of heterologous and homologous im-
munization with live bacteria on elimination of Listeria
monocytogenes (strain EGD) from the liver.Fourteen days
before challenge female ICR mice were given 0.01 of an
LDso of L. monocytogenes strain EGD (LM) or Salmonella
typhimurium (wild-type; ST) iv. Immunosuppression with
cortisone acetate (CA) was started 36 h before iv challenge
with 3.8 x 104 cfu of L. monocytogenes. Values at each
time point are mean log cfu from the liversof five animals.
CA: each animal received 2.5 mg/day of cortisone acetate
for 3 days. Note that the total volume of liver homoge-
nate was 5 ml and that >85070 of the inoculum was recov-
ered from the liver 10 min after challenge (for methods
see [15]).
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increasingly resistant to immunosuppression by glu-
cocorticoids during the course of infection. He con-
cluded that, while the developmental stage of im-
munity was highly sensitive to glucocorticoids,
established immunity became increasingly less sus-
ceptible [11]. Ifwecompare these observations to our
finding that the antimicrobial activity of macro-
phages may be the critical target for the immunosup-
pressive effect of glucocorticoids for infection with
intracellular pathogens such as Listeria, we would
expect that the antilisterial capacity of "activated"
macrophages is unaffected by glucocorticoids and
that "adoptive glucocorticoid resistance" is non-
specific. Indeed, when mice are infected with a
sublethal dose of S. typhimurium 14 days before
treatment with glucocorticoid and are then chal-
lenged with Listeria, the immunosuppressive effect
of cortisone on early listeriosis is no longer appar-
ent. Heterologous immunization thus results in the
elimination of Listeria from the livers of cortisone-
treated animals that is even better than the elimina-
tion of the organisms from normal control animals
(figure 4). This adoptive glucocorticoid resistance is
not affected by concurrent exposure of immunized
mice to glucocorticoid and cytotoxicdrugs that abol-
ish the mobilization of bone marrow-derived phago-
cytes (data not shown).
In these experiments it is of importance that the
failure of glucocorticoid-treated animals to mobi-
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Figure 6. Effect of glucocorticoids and interferon-yon
the elimination of Listeria monocytogenes ingested by hu-
man blood-derived macrophages cultured in vitro for 36 h
before challenge. Values are the mean percentage (± SD)
of cells from quadruplicate wells that eliminated ingested
bacteria during 8 h of incubation, as determined by enumer-
ation of bacteria in May-Giemsa-Griinwald-stained mono-
layers (methods according to [10)).Supplements added to
the macrophage cultures before challenge were as follows.
DEXA: 2.5 x 10 -7 M dexamethasone for 36 h; IFN: 120
units of human recombinant interferon-v/ml 0-36 h be-
fore challenge; HCS: 100 JJ.g of hydrocortisone succinate
added 18h before challenge; HCS/IFN: 100JJ.g of hydro-
cortisone succinate 18 h before challenge and 120 units
of interferon-y 12h before challenge. Note that interferon-y
restored the listericidal activity of macrophages in the con-
tinuous (36 h) presence of dexamethasone; suprapharma-
cologie concentrations of hydrocortisone added to cultures
for only 18h had no effect on the antilisterial activity and
did not inhibit the restoration by interferon-v of the an-
timicrobial function of dexamethasone-treated cells.
rophages against Toxoplasma gondii in the presence
of high concentrations of hydrocortisone.
Although the antilisterial activity of dexametha-
sone-treated macrophages is restored by interferon-
y, this lymphokine has no effect on the anticonidial
activity of macrophages and thus does not correct
for the dexamethasone effect on the anticonidial ac-
tivity of human alveolar or blood-derived macro-
phages [10].
In accordance with the apparently opposing ef-
fects of dexamethasone and interferon-yon anti-
listerial activity of macrophages, activation of the
antilisterial potential of the macrophage is not sup-
pressed by the addition of pharmacologic concen-
trations of dexamethasone to mixed-cell systems
composed of proliferating lymphocytes (stimulated
by a mitogen or by an antigen) and macrophages,
in spite of a marked suppression of lymphocyte
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Figure 5. Inability of bone marrow suppression to af-
fect the course of early listeriosis in normal (+1+) and
athymic (nu/nu) BALB/c mice. Ablation of bone marrow
with nitrogen mustard, a treatment resulting in severeleu-
kopenia and in a complete loss of the ability to mount
a cellular inflammatory response to heat-killed bacteria
in the peritoneal cavity,does not affect the course of listeri-
osis induced by a low challenge dose of a wild-type strain
of Listeriamonocytogenes over 4 days of infection. Each
point represents the mean log cfu from four to six animals
(figure is modified from [15]).
lize mononuclear phagocytes is not alleviated by
prior immunization (figure 7). These observations
provethat resistanceto glucocorticoid that is induced
by immunization with live bacteria does not reside
in the antigen-specific afferent limb of cell-mediated
immunity, i.e., in T cells. The findings further indi-
cate that the effector cells, the macrophages resident
in the liver before challenge, become resistant to cor-
tisone after infection with Listeria or Salmonel/a.
Accordingly, we found that the antilisterial activity
of human blood-derived macrophages activated by
interferon-y is completely unaffected by pharmaco-
logic concentrations of dexamethasone in vitro [10].
Furthermore, glucocorticoids do not affect the acti-
vation of antilisterial activity by interferon-v, even
after macrophages are pretreated for prolonged
periods with pharmacologic concentrations of dexa-
methasone [10] or exposed to suprapharmacologic
concentrations of hydrocortisone succinate (figure
6). These observations are in agreement with those
of Nash et al. [20] that hydrocortisone does not in-
terfere with a lymphokine-mediated suppression of
intracellular replication of Legionellapneumophila
in human macrophages but is at variance with ob-
servations by Masur et ale [21] that crude lymphokine
preparations do not activate mouse peritoneal mac-
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Mechanisms of Glucocorticoid-Induced
Impairment of the Antimicrobial Activity
of Macrophages
Impairment of the antimicrobial activity of mono-
nuclear phagocytes by glucocorticoids appears to be
mediated by the glucocorticoid receptor, since the
dose-response curves for the functional defect
parallels the dissociation curve for a given glucocor-
ticoid and receptor. Furthermore, the effect is an-
tagonized in a dose-dependent manner by progester-
one, an antagonist at the hormone receptor [10].
Glucocorticoids have been shown to alter the me-
tabolism of arachidonic acid in vitro, suppressing the
synthesis of prostaglandins and leukotrienes [22].A
comparison of the effects of dexamethasone with
those of indomethacin, an inhibitor of prostaglan-
din synthesis, and nordihydroguaiaretic acid, a non-
specific lipoxygenase inhibitor that also affects leu-
kotriene synthesis, does not, however, suggest that
the effect of glucocorticoids on antimicrobial activ-
ity of macrophages acts by suppression of leu-
kotriene or prostaglandin synthesis (figure 8). The
results of transfer experiments with supernatants
from autologous cultures of monocytes indicate that
suppression of the secretion of monokines is not es-
sential for the effect of glucocorticoids on an-
timicrobial activity (figure 8).
In accordance with the findings of previous studies
of Blackwood and Pennington [23] in intact guinea
pigs, which suggested that glucocorticoids cause
defective intracellular killing without affecting pha-
proliferation [10]. As with interferon-y the an-
ticonidial activity of dexamethasone-treated cells is
not restored by proliferating lymphocytes. Since
pharmacologic concentrations of dexamethasone fail
to suppress the activation of antilisterial activity of
macrophages by proliferating lymphocytes in mixed-
cell systems but do not correct the dexamethasone-
induced defect of anticonidial activity, we conclude
that in this in vitro system the effector cell in cell-
mediated immunity is more susceptible to the im-
munosuppressive effect of glucocorticoids than is the
afferent limb, i,e., the proliferating lymphocytes
secreting lymphokines. It is of note, however, that
this in vitro model represents only incompletely the
functions required for a successful immune response
and omits important aspects such as the mobiliza-
tion of T cells to the site of infection, which may
be impaired by glucocorticoid in vivo [7].
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Figure 7. Effect of cortisone (CO) and immunization
with live bacteria (Listeria monocytogenes [LM] or Sal-
monella typhimurium [ST]) on an inflammatory mononu-
clear cellular response in the peritoneal cavity. Female ICR
mice were immunized and given cortisone as outlined in
figure 4. 1\venty-four hours before mice were killed, an
inflammatory cellular response was initiated by injecting
them ip with 109 heat-killed L. monocytogenes organisms
(120°C, 15 min) suspended in saline. Peritoneal cells were
enumerated and differentiated as described [8]. Note that
neither homologous (LM) nor heterologous (ST) immu-
nization alleviated the suppression of the inflammatory
cellular response to the stimulus. Results are for one typi-
cal experiment of two experiments.
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Figure 8. Effects of dexamethasone, inhibitors of leuko-
triene and prostaglandin synthesis, cyclosporin A, and
macrophage supernatant on the elimination of Listeria
monocytogenes from human blood-derived macrophages.
Before challenge with L. monocytogenes, human mono-
nuclear phagocytes were exposed for 36 h to cyclosporin
A (2 ug/ml), indomethacin (20 J,LM), nordihydroguaiaretic
acid (NDGA; 10-6 M), dexamethasone (2.5 x 10-7 M), or
medium (100070) conditioned for 36 h in homologous
mononuclear cell cultures (M0-SN). Values are the mean
percentage (± SD) of cells from quadruplicate wells that
eliminated ingested bacteria during 8 h of incubation af-
ter challenge (for methods see figure 6).
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Figure 9. Failure of dexamethasone
to prevent fusion of lysosomes with
phagosomescontaining sporesfrom As-
pergillusfumigatus in human blood-de-
rived macrophages. Human blood-de-
rived macrophages wereexposed for 36
h to 2.5 X 10-7 M dexamethasone be-
fore challenge with spores. Electron
micrographs of macrophages 4 h after
phagocytosis show acid phosphatase
activity (arrows) in phagosome of a
control cell (top) and in a dexametha-
sone-treated cell (middle); no activity
is seen in the substrate control (bottom)
(final magnification, x 14,000).
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gocytosis, our observations of pure phagocyte sys-
tems showed that glucocorticoids directly impair the
ability of macrophages to kill ingested microorgan-
isms. Because the anticonidial activity of macro-
phages is independent of oxidative killing systems
[10, 24], the target for the glucocorticoid effect at
the cellular level appears not to lie in the systems
that generate reactive oxygen intermediates. In fact,
we found that mononuclear phagocytes from chil-
dren with chronic granulomatous disease - which are
unable to mount a respiratory burst - not only han-
dle spores from Aspergillus as efficiently as do cells
from normal volunteers, but are equally affected
functionally by glucocorticoids [10]. Furthermore,
dexamethasone treatment of human blood-derived
macrophages for 36 h does not affect or only mini-
mally affects the generation of hydrogen peroxide
or chemiluminescence in a luminol- or lucigenin-
amplified system upon stimulation with phorbol
myristate acetate (PMA) or opsonized zymosan
(authors' unpublished observation). It has been pro-
posed by Merkow et al. that lysosomes in macro-
phages exposed to cortisone do not fuse with phago-
somes harboring conidia from Aspergillus [25]. To
date we have no evidence in our in vitro model that
phagosome-lysosome fusion is disturbed by dexa-
methasone in cells unable to confine spores (figure
9). Furthermore, alveolar macrophages from mice
treated wtih cortisone and challenged with aerosol-
ized spores ofAspergillusfumigatus show that lyso-
somes, which were visualized by cytochemical meth-
ods [26], fuse readily with phagosomes containing
spores (authors' unpublished observation).
Taken together, these observations indicate that
macrophages exposed to glucocorticoids ingest mi-
croorganisms at a normal rate and that after phago-
cytosis they secrete the usual reactive oxygen inter-
mediates and exhibit normal fusion of lysosomes and
phagosomes. Hence, glucocorticoids apparently af-
fect nonoxidative killing systems, which appear to
play an impotant role in natural resistance against
a broad range of microorganisms. We postulate that
this microbicidal system would be operative in "rest-
ing," i.e., nonactivated, macrophages but that its ac-
tivity would be lost under the influence of glucocor-
ticoids. Possibly glucocorticoids act by suppressing
the synthesis of one or several specific proteins of
nonoxidative killing systems, the suppressive effects
being comparable to those of glucocorticoids on the
synthesis of elastase, collagenase, and plasminogen
activator that were first noted by Werb [27]. Such
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a catabolic effect would also explain why macro-
phages must be exposed for 24-36 h to glucocorti-
coids before any damage to the cells' antimicrobial
activity becomes evident [10].
By activating macrophages, interferon enhances
the secretion of reactive oxygen intermediates in re-
sponse to a phagocytic stimulus [28]. The interferon-
y corrects for the glucocorticoid-induced impairment
of the antilisterial activity of macrophages but can-
not correct for such a loss of activity against Asper-
gillus spores or Nocardia [10], two pathogens resis-
tant to oxidative killing by neutrophil granulocytes
[23,29]. Our hypothesis therefore proposes that oxi-
dative killing systems ofglucocorticoid-treated macro-
phages normally react to interferon-y and are nor-
mally primed to secrete reactive oxygen intermediates
upon challenge. The damage to hitherto unidenti-
fied nonoxidative killing systems in glucocorticoid-
treated phagocytes would not, however, be alleviated
by lymphokine activation. Indeed, we now have evi-
dence that activation of the capacity to secrete H 20 2
or O2- by interferon-v-activated macrophages is not
impaired by glucocorticoids and that restoration by
interferon-y of the antilisterial activity of macro-
phages after their exposure to glucocorticoids parallels
the activation of systems that generate reactive oxy-
gen intermediates (authors' unpublished observation).
Conclusions
Resident tissue macrophages deployed in great num-
bers at critical anatomic sites, such as Kupffer cells
and alveolar macrophages, appear to be critical tar-
gets for the actions of glucocorticoids that compro-
mise the natural resistance of the host. Therapeutic
concentrations of glucocorticoids prevent the destruc-
tion of microorganisms ingested by macrophages
without interfering with phagocytosis, phagosome-
lysosome fusion, and/or the secretion of reactive ox-
ygen intermediates. These findings indicate that at
the cellular level the glucocorticoid target should be
looked for in the nonoxidative antimicrobial arma-
ture of the phagocyte and point out that nonoxida-
tive killing systems of resident tissue macrophages
play an important role in natural resistance to op-
portunistic pathogens. Glucocorticoids do not pre-
vent lymphokine-induced activation of the macro-
phages' oxidative killing system. Lymphokines such
as interferon-y thus can restore the microbicidal ac-
tivity of glucocorticoid-suppressed macrophages
against organisms susceptible to reactive oxygen in-
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termediates in vitro and most likely can restore the
activity in vivo; hence, "glucocorticoid resistance"
induced by "established immunity" to an unrelated
pathogen seemsto residein the macrophage and does
not require specific T cell interactions. For other
potential pathogens that are more resistant to ox-
idative killing, such as Aspergillus spores and
Nocardia, efficient killing depends on other,
glucocorticoid-sensitive, mechanisms whose activi-
ties cannot be restored by interferon-y. The host's
inability to counterbalance the effect of glucocorti-
coids on these defense mechanisms thus might help
explain the peculiar susceptibility ofglucocorticoid-
treated and hypercortisolemic patients to infection
with such opportunistic organisms. The nature of
the glucocorticoid-sensitive killing mechanisms re-
mains to be elucidated.
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